CORESTEMCHEMON Inc. (KOSDAQ:166480)
2,700.00
-45.00 (-1.64%)
At close: Mar 12, 2026
CORESTEMCHEMON Market Cap
CORESTEMCHEMON has a market cap or net worth of 119.77 billion as of March 13, 2026. Its market cap has increased by 39.68% in one year.
Market Cap
119.77B
Enterprise Value
167.34B
Revenue
20.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,700.00
Market Cap Chart
Since June 26, 2015, CORESTEMCHEMON's market cap has decreased from 653.85B to 119.77B, a decrease of -81.68%. That is a compound annual growth rate of -14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 119.77B | 46.10% |
| Dec 30, 2025 | 81.98B | -13.27% |
| Dec 30, 2024 | 94.52B | -34.79% |
| Dec 28, 2023 | 144.95B | -43.25% |
| Dec 29, 2022 | 255.40B | -13.00% |
| Dec 30, 2021 | 293.58B | -19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 117.74B |
| ViGenCell | 117.46B |
| BIO-FD&C | 116.61B |
| NovMetaPharma | 114.16B |
| Progen | 102.24B |
| Quratis | 98.72B |
| Cell Biotech | 93.08B |
| TegoScience | 93.04B |